Cannabis Stocks

THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

Jul 9, 2025

Ten-Year Legacy Brand Joins THCT Portfolio, Expanding National Craft Cannabis Footprint and Female-Founded Leadership Medford, OR, July 8, 2025 - PRISM MediaWire - THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the legal and regulated cannabis industry, is proud to announce the acquisition of all issued and outstanding membership interests of STHoldings Group LLC, the parent company of iconic Eugene, Oregon cannabis brand SugarTop Buddery, in an all-share...

THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies

Jun 24, 2025

Breakthrough Transaction Unites Segment Leaders into a Powerful and Flexible Player in the Legal Cannabis Industry Medford, OR, June 24, 2025 - PRISM MediaWire - THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the emerging and dynamic legal and regulated cannabis industry, announced today that it has acquired all of the issued and outstanding ownership interests of The Headquarters Group, Inc. (“THG”) in an all-share transaction valued at...

SutimCo Inc. – New Merger/Acquisition and Product Line Release

Sep 13, 2023

DALLAS, TX, September 13, 2023 - SutimCo Inc. (OTC PINK: SUTI) (the “Company) is proud to announce the completion of Auri Inc. (OTC PINK: AURI) ("AURI") (the "Company"), acquiring SutimCo International Inc. “We are “on track” with our roll-up plans and companies' acquisitions. We already see a tremendous possibility in our “vertical integration” of products and services. The companies that are signing up also include PBHG, PRPM and BDGR. Auri Inc. is the “tip of the spear” for the...

Bloomios Reports Q2 2023 Financial Results

Aug 30, 2023

Quarterly Revenue More Than Doubles to $2.7 Million Year-to-Date Revenue up 96% to $5.4 Million SANTA BARBARA, Calif., August 30, 2023 - Bloomios, Inc. (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, reported results for the second quarter ended June 30, 2023. All comparisons are to the same year-ago period unless otherwise noted. Q2 2023 Highlights Revenue totaled $2.7 million, up 111% compared to...

NEWSROOM

THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies

SutimCo Inc. – New Merger/Acquisition and Product Line Release

Bloomios Reports Q2 2023 Financial Results

Contact Us